Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

PRP mesotherapy can effectively treat male hair loss with minimal side effects.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

The combination therapy is safe and effective for treating Female Pattern Hair Loss in Asian women.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Antiandrogens like spironolactone can help treat female-pattern hair loss.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Topical spironolactone effectively treats hair loss in women.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

A 36-year-old woman with worsening hair loss over 10 years was treated with various medications, and after six months, her hair loss did not worsen significantly.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

PCOS is a common inherited condition causing cysts, irregular periods, and increased diabetes risk in women.

Clascoterone 1% cream is a promising new treatment for acne.

Treating stubborn hair loss involves both medical and emotional support options.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Different medications can cause serious side effects in some people.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Strontium ranelate is no longer available for treatment.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.